Deadline Looms for Applications to Host EMA
European Union countries have until midnight on July 31 to enter the bidding contest to provide a new home for European Medicines Agency (EMA). About 20 applications are expected, according to a report on the BBC News website.
The European Banking Authority and the EMA, both based in Canary Wharf in London, employ just over 1,000 staff between them, and the agencies will be relocated from the UK after Brexit.
“There will be fierce competition to attract the agencies’ highly skilled employees, their families and the business that comes with them. This includes 40,000 hotel stays for visitors each year,” the BBC article noted. “Countries have printed glossy brochures, posted promotional videos online and hired lobbying firms.”
The European Commission will assess the entries based on the quality of office space, job opportunities for spouses, and transport links, and European ministers will use a complicated voting system to choose the winners in November, the report added.
Philip Ward is the European Editor for Applied Clinical Trials.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Full Phase IIIb BATURA Trial Results Show Airsupra Cuts Severe Exacerbations by 47% in Mild Asthma
May 20th 2025Results from the pivotal BATURA trial show that Airsupra (albuterol/budesonide) significantly outperformed albuterol monotherapy in reducing severe asthma exacerbations and systemic corticosteroid exposure, reinforcing its role as a next-generation, anti-inflammatory rescue therapy for mild asthma patients.
